Results of a clinical pharmacokinetic (PK) bioequivalence (BE) study of liposomal paclitaxel (LEP-ETU) versus paclitaxel (T) in patients with advanced cancer.
暂无分享,去创建一个
H. Rosing | A. Tan | H. Gelderblom | M. Scheulen | E. Rubin | V. Shu | J. Sherman | L. V. van Warmerdam | A. Hanauske | G. Fetterly